HAMBURG (dpa-AFX Broker) - Hauck Aufhäuser Investment Banking has downgraded Stratec from "Buy" to "Hold" ahead of figures and lowered the price target from 50 to 40 euros. Analyst Alexander Galitsa is becoming more cautious in view of the upcoming publication of the 2023 annual figures and the company's outlook for 2024. The diagnostics specialist's outlook is likely to be cautious, the expert wrote in a study published on Monday. There are uncertainties after demand in the molecular diagnostics segment was high during the coronavirus pandemic - meaning customers brought forward orders. In addition, in view of the high working capital, improvements are unlikely to occur before 2025, as the purchase commitments made to suppliers during the pandemic - to ensure availability - are still in force./mis/tih

Publication of the original study: 22.01.2024 / 07:55 / CET

First dissemination of the original study: 22.01.2024 / 08:05 / CET

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------